The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA).
- Investigator
- Anita Rajasekhar
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Update your location to show providers, locations, and services closest to you.
Cancer Specialist (Oncologist), Hematologist (Blood Disease Specialist), Hematology and Oncology Specialist
The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA).
50 publications
2022
Journal of thrombosis and thrombolysis
PubMed • Publisher's site2022
Journal of cardiothoracic and vascular anesthesia
PubMed • Publisher's site2022
Journal of thrombosis and thrombolysis
PubMed • Publisher's site2022
Cureus
PubMed • Publisher's site2022
BMJ case reports
PubMed • Publisher's site